Get started
Author

Mathilde Morisseau

Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer
2024 · F. Poumeaud, M. Morisseau, et al. · British Journal of Cancer · 73
PDF
Abstract PS08-02: Efficacy of Sacituzumab-Govitecan (SG) post Trastuzumab-deruxtecan (T-DXd) and vice versa for HER2low advanced or metastatic breast cancer (MBC): a French multicentre retrospective study
2024 · François Poumeaud, Mathilde Morisseau, et al. · Cancer Research · 16
The prognostic value of tumor-infiltrating lymphocytes in vulvovaginal melanoma
2024 · Margaux Vanbockstael, Guillaume Bataillon, et al. · International Journal of Gynecological Cancer · 7
Impact of comprehensive geriatric assessment on treatment decisions in older prostate cancer patients
2025 · Maëva Bonneau, Zara Steinmeyer, et al. · BMC Cancer · 6
PDF
High-Dose-Rate Brachytherapy for Treatment of Facial Skin Cancers: Local Control, Toxicity, and Quality of Life in 67 Patients
2024 · Jeanne Monge-Cadet, Benjamin Vairel, et al. · Cancers · 4
312P Efficacy of sequential antibody-drug conjugates (ADCs) targeting topoisomerase-1 in HER2-low metastatic breast cancer (MBC): Updated results and additional analyses from the French multicenter retrospective ADC-low cohort
2025 · F. Poumeaud, M. Morisseau, et al. · ESMO Open · 3
PDF
Videofluoroscopic swallowing study to detect pharyngeal leak after total (pharyngo‐) laryngectomy: Retrospective assessment of a single‐institution protocol
2024 · Emilien Chabrillac, Lucile Baudel, et al. · Head & Neck · 3
Intraepithelial tumor-infiltrating lymphocytes shape loco-regional PET/CT spread of locally advanced cervical cancer
2024 · Mathilde Del, Claire Illac, et al. · International Journal of Gynecological Cancer · 2
Abstract PD3-08: Evidence Accumulates Against Sequencing Topo1-ADCs in HER2-Low Metastatic Breast Cancers: results from International, retrospective, real-world ADC-Low-Europe cohort
2026 · F. Poumeaud, M. Morisseau, et al. · Clinical Cancer Research · 1
Modernizing the assessment and reporting of adverse events in oncology clinical trials using complementary statistical approaches: a case study of the MOTIVATE trial
2024 · Mathilde Morisseau, Carlos Gomez-Roca, et al. · Investigational New Drugs · 1
Persistent TOP1 cleavage complexes in drug-tolerant cells drive adaptive resistance to EGFR-targeted therapies in lung cancer
2026 · Mathéa Geraud, Remi Gence, et al. · Science Advances
Semi-parametric modelling for analysing the evolution of toxicities over time
2026 · Mathilde Morisseau, Patrick Sfumato, et al. · BMC Medical Research Methodology
Shallow Whole-Genome Sequencing (sWGS) Identifies a Copy Number–High Subset of TP53-Mutated Multiple-Classifier Endometrial Carcinomas With Adverse Clinicopathological Features
2026 · Guillaume Bataillon, Thomas Volosov, et al. · Modern Pathology
Postoperative Hemoglobin and Transfusion Rates Do Not Influence Revision of Head and Neck Free Flap in a Cohort of 259 Patients
2026 · Olivier Gilbert, Agnès Dupret‐Bories, et al. · Head & Neck
PDF
Usefulness of routine clinical follow-up after oral cavity cancer treatment: a single-center retrospective study
2026 · Alexandre Guibert, Sébastien Vergez, et al. · European Journal of Surgical Oncology
PDF
Semi-parametric modelling for analysing the evolution of toxicities over time
2026 · M. Morisseau, P. Sfumato, et al. · Journal of Epidemiology and Population Health
821 Two decades of insight: key findings from a French retrospective multicenter analysis of pediatric localized intracranial ependymoma (NCT05151718)
2026 · Fatima TENSAOUTI, Alexis Marguerit, et al. · Radiotherapy and Oncology
Systemic Treatments for Recurrent or Metastatic Sinonasal Carcinomas: A Retrospective Multicenter Study
2026 · Marie Degrange, Mathilde Morisseau, et al. · Head & Neck
Bone marrow 18F-FDG PET/CT metabolic activity: a surrogate marker for inflammation tumor load in patients with advanced ovarian cancer.
2026 · Anne-Sophie Navarro, Mathieu Sinigaglia, et al. · International Journal of Gynecological Cancer
Prognostic factors for early recurrence of oral cavity squamous cell carcinoma: a single-center retrospective study
2026 · Alexandre Guibert, Mathilde Morisseau, et al. · SSRN Electronic Journal
Impact of Neoadjuvant Immunochemotherapy on Surgical Outcomes in Management of Early Triple‐Negative Breast Cancer
2026 · Tamasine Khadrouche, Mathilde Morisseau, et al. · The Breast Journal
3282 Pediatric localized intracranial ependymoma: survival, prognostic factors in a French multicentric retrospective study from 2000 to 2021 (NCT05151718)
2025 · Alexis Marguerit, Fatima Tensaouti, et al. · Radiotherapy and Oncology
3629 Tolerance of adjuvant radiotherapy after neoadjuvant chemo-immunotherapy for triple-negative breast cancer and impact of the immunotherapy regimen.
2025 · Ludovic Hernandez, Tamasine Khadrouche, et al. · Radiotherapy and Oncology
1249 Radiomics prognostication model in pediatric ependymoma using diffusion-weighted imaging (NCT05151718)
2025 · Fatima Tensaouti, Nhi Blanchard, et al. · Radiotherapy and Oncology
849: Relapse Risk stratification in pediatric ependymoma patients using clinical data and radiomics
2024 · Fatima Tensaouti, Nhi Blanchard, et al. · Radiotherapy and Oncology
Works count: 27
Citation count: 116
H-index: 4
I10-index: 2
Year
Topic
Type